PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
42 hedge funds and large institutions have $21.8M invested in Paratek Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
92% less call options, than puts
Call options by funds: $46K | Put options by funds: $554K
Holders
42
Holding in Top 10
1
Calls
$46K
Puts
$554K
Top Buyers
| 1 | +$321K | |
| 2 | +$213K | |
| 3 | +$165K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$104K |
| 5 |
Morgan Stanley
New York
|
+$90.1K |
Top Sellers
| 1 | -$316K | |
| 2 | -$182K | |
| 3 | -$165K | |
| 4 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
-$158K |
| 5 |
Millennium Management
New York
|
-$109K |